Can Denosumab Prevent Breast Cancer?
From Osteoporosis to Breast Cancer Denosumab, a biologic agent, and bisphosphonates, which are small molecule drugs, reduce fractures that are complications of osteoporosis, including those caused by breast cancer hormone therapies that block estrogen signaling, menopause, or surgically-induced menopause (oophorectomy with or without hysterectomy). Both denosumab and bisphosphonates also reduce the risk of bone metastasis … Read more